SGDL Health SA revolutionizes genomic data management with advanced spatial computing and multidimensional indexing. Our secure, scalable, AI-driven solutions empower precision medicine and accelerate genomic research.
Products, services, technology
SGDL Health SA delivers advanced genomic data management solutions using AI and spatial computing. Our portfolio features multidimensional indexing, secure cloud integration, and federated query platforms to empower precision medicine and research.
Cooperation possibilities
Partner with SGDL Health SA to drive innovation in genomic data management. We welcome collaborations with industry, academia, and healthcare to co-develop secure, AI-driven solutions for precision medicine and accelerated discovery.
- https://sgdl.health
- +41 79 428 99 99
- Send an email
- Alex Kummerman
Some insights
SGDL empowers precision medicine with secure, AI-driven genomic data management. We accelerate research for faster disease detection and personalized treatments, ultimately improving healthcare outcomes and quality of life worldwide.
SGDL’s pioneering, AI-driven genomic solutions transform data into actionable insights for precision medicine, accelerating research and improving healthcare worldwide. We’re proud to lead innovation that saves lives.
We admire leaders like Illumina, DNAnexus, and the Broad Institute. Their groundbreaking work in genomics, data analytics, and precision medicine inspires our drive to create innovative, secure genomic solutions.
Our team excels in genomic data science, spatial computing, AI, and secure cloud integration. We look forward to integrating experts in quantum-safe encryption, federated data management, and advanced bioinformatics to further drive precision medicine.
My family would say I’m a health data wizard—turning complex genomic puzzles into secure, innovative solutions that advance personalized medicine and improve lives.
The Swiss biotech ecosystem can support us best by offering strategic funding, fostering industry-academic collaborations, streamlining regulations, and connecting us with global networks to accelerate innovation and market access.
We seek to connect with academic research centers, biotech/pharma companies, venture capital, healthcare providers, regulators, and tech innovators. Collaboration with these stakeholders is key to advancing genomic innovation and precision medicine.